Fibronectin fragments modulate human retinal capillary cell proliferation and migration

Diabetes

Volumn 47, Issue 8, 1998, Pages 1335-1340

  Grant, Maria B ^a,b   Caballero, Sergio ^a   Bush, David M ^a   Spoerri, Polyxenie E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GELATINASE A;

ANGIOGENESIS; ARTICLE; CELL COUNT; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; DIABETIC RETINOPATHY; DNA SYNTHESIS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PERICYTE; PRIORITY JOURNAL; RETINA CAPILLARY; SMOOTH MUSCLE FIBER;

EID: 0031822516     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.8.1335     Document Type: Article

References (38)

1. Ingber D: Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem 47:236-241, 1991
2. Liotta LA, Tryggyason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymic degradation of basement membrane collagen. Nature 284:67-68, 1980
3. Ruoslahti E: Fibronectin and its receptors. Annu Rev Biochem 57:375-413, 1988
4. Humphries MJ, Ayad SR: Stimulation of DNA synthesis by cathepsin D digests of fibronectin. Nature 305:811-813, 1983
5. Postlethwaite AE, Keski-Oja J, Balian G, Kang AH: Induction of fibroblast chemotaxis by fibroneotin: localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med 153:494-499, 1981
6. Tsukamoto Y, Helsel WE, Wahl SM: Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol 127:673-678, 1981
7. Grant MB, Caballero S, Tarnuzzer RW, Bass KE, Ljubimov A, Spoerri PE, Galardy RE: Matrix metalloproteinase expression in cultured human retinal microvascular cells. Diabetes 47:1317-1323, 1998
8. Grant MG, Guay C: Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin. Invest Ophthalmol Vis Sci 32:53-64, 1991
9. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ: Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis? Circulation 89:1511-1517, 1994
10. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA: An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548, 1989
11. Grant M, Jerdan J, Merimee TJ: Insulin-like growth factor-I modulates endothelial cell chemotaxis. J Clin Endocrinol Metab 65:370-371, 1987
12. Courtoy PJ, Boyles J: Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. J Ultrastruct Res. 83:258-273, 1983
13. Das A, Frank RN, Zhang NL, Turczyn TJ: Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane. Arch Ophthalmol 108:421-429, 1990
14. Essner E, Lin WL: Immunocytochemical localization of laminin, type IV collagen and fibronectin in rat retinal vessels. Exp Eye Res 47:317-327, 1988
15. Jerdan JA, Glaser BM: Retinal microvessel extracellular matrix: an immunofluorescent study. Invest Ophthalmol Vis Sci 27:194-203, 1986
16. Roy S, Cagliero E, Lorenzi M: Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 37:258-266, 1996
17. Ellis E, Grant M, Murray F, Wachowski M, Gubersky DL, Kubilis PS, Lutty GA: Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Rad Biol Med 24:111-120, 1998
18. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, Sado Y, Huang ZS, Nesburn AB, Kenney MC: Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 44:1469-1479, 1996
19. Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zardi L: The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 59:612-618, 1994
20. Munjal ID, McLean NV, Blake DA, Grant MB: Differences in the synthesis of secreted proteins in human retinal endothelial cells of diabetic and nondiabetic origin. Curr Eye Res 13:303-310, 1994
21. Roy S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 87:404-408, 1990
22. Phan-Thanh L, Robert L, Derouette JC, Labat-Robert J: Increased biosynthesis and processing of fibronectin in fibroblasts from diabetic mice. Proc Natl Acad Sci U S A 84:1911-1915, 1987
23. Vaheri A, Mosher DF: High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta 516:1-25, 1978
24. van-Muijen GN, Danen EH, de-Vries TJ, Quax PH, Verheijen JH, Ruiter DJ: Properties of metastasizing and nonmetastasizing human melanoma cells. Recent Results Cancer Res 139:105-122, 1995
25. Chen WT, Lee CC, Goldstein L, Bernier S, Lin CH, Lin CY, Yeh Y, Monsky WL: Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res Treat 31:217-226, 1994
26. Gingras MC, Jarolim L, Finch J, Bowden GT, Wright JA, Greenberg AH: Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts. Cancer Res 50:4061-4066, 1990
27. Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R, Lider O, Fridkin M: Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides. Eur J Biochem 223:35-42, 1994
28. Mortarini R, Gismondi A, Santoni A, Parmiani G, Anichini A: Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin. Cancer Res 52:4499-4506, 1992
29. Yoshihara T, Ikushima S, Shimizu Y, Esumi N, Todo S, Humphries MJ, Imashuku S: Distinct mechanism of human neuroblastoma cell adhesion to fibronectin. Clin Exp Metastasis 9:363-375, 1991
30. Saiki I, Makabe T, Yoneda J, Murata J, Ishizaki Y, Kimizuka F, Kato I, Azuma I: Inhibitory effect of fibronectin and its recombinant polypeptides on the adhesion of metastatic melanoma cells to laminin. Jpn J Cancer Res 82:1112-1119, 1991
31. Makabe T, Saiki I, Murata J, Ohdate Y, Kawase Y, Taguchi Y, Shimojo T, Kimizuka F: Modulation of haptotactic migration of metastatic melanoma cells by the interaction. J Biol Chem 265:14270-14276, 1990
32. Huebsch JC, McCarthy JB, Diglio CA, Mooradian DL: Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin. Circ Res 77:43-53, 1995
33. Xie D, Hui F, Homandberg GA: Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro. Arch Biochem Biophys 307:118-118, 1993
34. Muir D, Manthorpe M: Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation. J Cell Biol 116:177-185, 1992
35. Werb Z, Hembry R, Murphy G, Aggeler J: Commitment to expression of the metalloendopeptidases, collagenase and Stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol 102:697-702, 1986
36. Aggeler J, Frisch SM, Werb Z: Changes in cell shape correlate with collagenase gene expression in rabbit synovial. J Cell Biol 98:1662-1671, 1984
37. Imhoff JM, Blondeau X, Planchenault T, Emod I, Keil-Dlouha V: Collagenase activation of latent matrix-degrading proteinases from human plasma. Biol Chem Hoppe Seyler 371:137-144, 1990
38. Stack S, Gray RD, Pizzo SV: Modulation of plasminogen activation and type IV collagenase activity by a synthetic. Biochemistry 30:2073-2077, 1991